Medicalgorithmics S.A.

Warsaw Stock Exchange MDG.WA

Medicalgorithmics S.A. Price to Earnings Ratio (P/E) on January 14, 2025: -289.99

Medicalgorithmics S.A. Price to Earnings Ratio (P/E) is -289.99 on January 14, 2025, a -15.98% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Medicalgorithmics S.A. 52-week high Price to Earnings Ratio (P/E) is -149.61 on November 26, 2024, which is 48.41% above the current Price to Earnings Ratio (P/E).
Medicalgorithmics S.A. 52-week low Price to Earnings Ratio (P/E) is -326.81 on December 03, 2024, which is -12.70% below the current Price to Earnings Ratio (P/E).
Medicalgorithmics S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is -227.85.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Warsaw Stock Exchange: MDG.WA

Medicalgorithmics S.A.

CEO	Mr. Maciej Gamrot
IPO Date	Nov. 9, 2011
Location	Poland
Headquarters	Central Tower
Employees	120
Sector	Health Care
Industries Medical Instruments Telehealth

Description

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.

Key trends

Past 5 years